ASX Announcements


 
    Simavita secures funding to focus on AlertPLUS technology  
 
    Simavita releases Appendix 4C for quarter 31 March 2019  
 
    Suspension from Official Quotation  
 
    Simavita announces extension of Convertible Notes  
 
    Simavita releases Appendix 4C 31 December 2018  
 
    Simavita announces variation to Convertible Note  
 
    Initial Director's Interest Notice  
 
    Final Director's Interest Notice  
 
    Simavita releases AGM results  
 
    Annual General Meeting Presentation  
 
    Simavita announces change to Board of Directors  
 
    Simavita releases updated Corporate Presentation  
 
    Appendix 3B  
 
    Simavita announces capital raising outcome  
 
    Simavita releases materials for 2018 Annual General Meeting  
 
    Simavita releases Appendix 4G & Corp. Governance statement  
 
    Simavita releases 2018 Annual Report  
 
    Simavita releases Appendix 4C  
 
    Simavita announces date of AGM  
 
    Becoming a substantial holder - Tiga Trading Pty Ltd  
 
    Simavita announces changes in substantial shareholders  
 
    Simavita releases Cleansing Notice  
 
    Simavita releases Appendix 3B  
 
    Reinstatement to Official Quotation  
 
    Simavita releases audited consolidated financial statements  
 
    Suspension from Official Quotation  
 
    Trading Halt  
 
    Simavita releases Prelim Final Report year ended 30 June 18  
 
    Simavita releases Market Update August 2018  
 
    Simavita signs first major marketing agreement - updated  
 
    Simavita signs first major marketing agreement  
 
    Simavita announces change in substantial shareholding  
 
    Simavita announces changes to top 20 securityholders  
 
    Simavita releases Appendix 3B  
 
    Simavita releases updated Appendix 4C  
 
    Simavita releases Appendix 4C  
 
    Appendix 3B  
 
    Simavita releases Appendix 3B & Cleansing Notice  
 
    Simavita releases updated Appendix 4C  
 
    Simavita releases Appendix 4C  
 
    Simavita lodges Corporate Governance Statement  
 
    Simavita releases results of SGM  
 
    Simavita releases updated SGM Proxy form  
 
    Simavita releases updated Securities Trading Policy  
 
    Simavita releases materials for Special General Meeting  
 
    Simavita secures commitment for $1.4m funding  
 
    Simavita obtains Receivable Finance Facility  
 
    Simavita releases Half Year Accounts  
 
    Appendix 3B  
 
    SVA Change of Company Secretary  
 
    Simavita releases Appendix 4C & Quarterly update  
 
    Simavita releases Appendix 3B & Cleansing Notice  
 
    Simavita releases results of 2017 AGM  
 
    Simavita releases Chairman's address to 2017 AGM  
 
    Simavita granted ASX waiver re Convertible Notes  
 
    Simavita releases 2017 Annual General Meeting materials  
 
    Simavita announces $1.35m financing  
 
    Simavita announces strategy progress update  
 
    Simavita announces change of AGM date  
 
    Simavita releases Appendix 4C and Quarterly update  
 
    Simavita releases 2017 Annual Report  
 
    Simavita receives $964k R&D Tax Incentive  
 
    Simavita announces the date of the AGM  
 
    Simavita releases audited Consolidated Financial Statements 30 June 2017  
 
    Simavita releases Appendix 4G  
 
    Simavita releases audited Consolidated Financial Statements  
 
    Simavita obtains Receivables Finance Facility  
 
    Simavita releases Appendix 4E and Preliminary Financials  
 
    Simavita lodges Appendix 4E and Preliminary Financials  
 
    Simavita Market Update  
 
    Response to ASX query  
 
    Simavita releases Appendix 4C and Quarterly update  
 
    Simavita releases Appendix 4C and Quarterly update  
 
    Appendix 3B  
 
    Amended Appendix 3B  
 
    Appendix 3B  
 
    Change in substantial holding  
 
    Simavita announces changes in Substantial holders  
 
    Simavita announces changes in substantial shareholders  
 
    Becoming a substantial holder  
 
    Cleansing Notice  
 
    Non-Renounceable Issue  
 
    Simavita announces change of Company Secretary  
 
    Notification of Shortfall of Rights Issue Offer  
 
    Simavita Rights Issue Offer Closing Date Reminder  
 
    Simavita advises research report available  
 
    Becoming a substantial holder  
 
    Simavita makes Substantial Shareholder disclosure  
 
    Simavita releases Cleansing Notice  
 
    Placement  
 
    Correspondence to holders re Rights Issue  
 
    Non-Renounceable Issue  
 
    Cleansing Notice  
 
    Simavita announces Placement and Entitlement Offer  
 
    Appendix 3B  
 
    Trading Halt  
 
    Simavita releases Appendix 4C  
 
    Simavita releases Appendix 4C  
 
    ASX Announcement 27 March 2017  
 
    Simavita announces Strategy Update  
 
    Simavita releases interim financial statements 31 December 2016  
 
    Simavita releases interim financials 31 December 2016  
 
    Simavita releases Appendix 4C and Quarterly update  
 
    Simavita releases Appendix 4C and Quarterly update  
 
    $1.65m cash RnD tax incentive received  
 
    Simavita receives $1.65m R&D Tax Incentive  
 
    Change of Director's Interest Notice  
 
    Appendix 3B  
 
    Interim financials 30 September 2016 refiled  
 
    Simavita releases Interim financial statements and MDA 30 September 2016  
 
    Simavita releases MD&A & unaudited financial statements  
 
    Simavita releases results of 2016 AGM  
 
    Simavita releases presentation to 2016 AGM  
 
    Simavita releases Home Care system AssessPLUS  
 
    ASX Listing Rule Waivers  
 
    Simavita releases AGM materials  
 
    Simavita releases Annual Report 2016  
 
    Appendix 4G and Corporate Governance Statement  
 
    Simavita releases Appendix 4C amended  
 
    Simavita releases Appendix 4C as at 30 September 2016  
 
    Simavita Progress Update  
 
    Appendix 3B  
 
    Simavita releases full year results & Appendix 4E  
 
    Simavita releases Appendix 4C 30 June 2016  
 
    Simavita voluntarily delists from TSX-V  
 
    Change of Director's Interest Notice  
 
    Change of Director's Interest Notice  
 
    Appendix 3B  
 
    Appointment of Joint Company Secretary  
 
    Simavita Securities Trading Policy  
 
    Simavita - Becoming a substantial holder  
 
    Simavita - Change in substantial holding  
 
    Simavita - Change of Director's Interest Notice  
 
    Change in substantial holding  
 
    Simavita Results of Capital Raising  
 
    Simavita Cleansing Notice  
 
    Appendix 3B  
 
    Results of Special General Meeting  
 
    2016 Special General Meeting Presentation  
 
    Simavita releases MD and A and unaudited financial statements  
 
    Simavita releases Special Meeting materials  
 
    Final Director's Interest Notice - Craig Holland  
 
    Director resignation  
 
    Initial Director's Interest Notice - G Pace  
 
    Final Director's Interest Notice - Philippa Lewis  
 
    Appendix 4C - quarterly  
 
    Reinstatement to Official Quotation  
 
    Simavita Capital management and Board changes  
 
    Suspension from Official Quotation Immediately  
 
    Simavita to integrate with leading North American EHR  
 
    Cleansing notice  
 
    Significant shareholder disclosure  
 
    Appendix 3B - Securities released from escrow  
 
    Appendix 3B  
 
    Placement and Appendix 3B  
 
    Half Year Results  
 
    Half Year Report and Accounts  
 
    Results of Special General Meeting  
 
    Results of Security Purchase Plan & Appendix 3B  
 
    Simavita strategy update  
 
    Simavita Danish distributor Abena signs multi site contract  
 
    Release of restricted securities from escrow  
 
    Cleansing Notice  
 
    Disclosure under ASX Listing Rule 3.10.5A  
 
    Appendix 3B  
 
    Notice of Extraordinary General Meeting/Proxy Form  
 
    Philippa Lewis discusses current capital raising activities  
 
    Simavita Security Purchase Plan Offer Documents  
 
    Simavita announces Security Purchase Plan  
 
    Appendix 4C - quarterly  
 
    $1.27m cash R&D Tax Incentive received  
 
    Capital raising update  
 
    Trading Halt  
 
    Progress update - 6 January 2016  
 
    Resignation of Company Secretary  
 
    Simavita releases results of 2015 AGM  
 
    Simavita releases 2015 AGM presentation  
 
    Simavita releases MD&A and unaudited financial statements  
 
    Simavita to integrate with Health Metrics' eCase system  
 
    Simavita releases 2015 AGM materials  
 
    ASX Appendix 4C and market uptake data  
 
    Simavita releases 2015 Annual Report  
 
    North American sales and distribution update  
 
    Queensland Department of Health to fund deployment of SIM  
 
    Appendix 3B - 22 September 2015  
 
    Business update - 21 September 2015  
 
    Simavita investor newsletter - September 2015  
 
    Investor presentation  
 
    Release of 2015 financial results and Appendices 4E and 4G  
 
    ASX Appendix 4C - 30 June 2015  
 
    North American sales and marketing update  
 
    ASX Appendix 3B  
 
    Philippa Lewis discusses recent agreements  
 
    Sales and marketing agreement with Hartmann  
 
    Cancellation of options  
 
    Investor presentation  
 
    Simavita to integrate with MatrixCare  
 
    Simavita and Bunzl announce sales and marketing pa  
 
    Release of March 2015 financial reports  
 
    Cleansing notice, Appendix 3B and Appendices 3Y  
 
    Results of Special Meeting and ASX Appendix 3X  
 
    ASX Appendix 4C - 31 March 2015  
 
    Meeting documents  
 
    Simavita newsletter - April 2015  
 
    Simavita grants executive options  
 
    Notice of initial substantial shareholder  
 
    Cleansing notice and ASX Appendix 3B  
 
    Simavita closes $8.3 million private placement  
 
    Trading Halt  
 
    Simavita investor presentation and video  
 
    Simavita progress update  
 
    Proposed appointment of new Director  
 
    ASX Appendix 4D and financial statements  
 
    Receipt of $1.37 million R&D tax payment  
 
    CEO discusses recent announcements  
 
    ASX Appendix 4C - 31 December 2014  
 
    Simavita signs up Danish distributor  
 
    Release of securities from escrow  
 
    Simavita releases US investor presentation  
 
    Appointment of Chairman  
 
    Progress update  
 
    Results of 2014 Annual General and Special Meeting  
 
    2014 AGM presentation materials  
 
    Financial results and MD&A - 30 September 2014  
 
    2014 Annual Report  
 
    Appointment of Craig Holland as Director  
 
    Simavita Investor Newsletter November 2014  
 
    Progress update  
 
    Appendix 4C - quarterly  
 
    2014 Annual General and Special Meeting materials  
 
    Appendix 3B  
 
    Lorien Health Systems in US to roll out SIM  
 
    Resignation of Chairman  
 
    CEO, Philippa Lewis discusses Financial Results & Update  
 
    ASX Appendix 4E and audited Financial Report  
 
    ASX Appendix 3B  
 
    Progress update - 19 August 2014  
 
    Significant shareholder disclosure  
 
    Appendix 3Y - Damien Haakman  
 
    Appendix 3Y - Peter Cook  
 
    Appendix 3Y - Ari Bergman  
 
    Appendix 3Y - Philippa Lewis  
 
    Results of Special Meeting  
 
    Simavita presents at Bioshares Biotech Summit, New Zealand  
 
    Progress update  
 
    Cleansing notice and ASX Appendix 3B  
 
    ASX Appendix 4F  
 
    Meeting documents and SPP offer document  
 
    Capital raising update  
 
    Trading Halt  
 
    Investor newsletter  
 
    Interim financial statements and MD&A - 31 March 2014  
 
    Response to ASX Price Query  
 
    ASX Appendix 4C  
 
    Change of balance date  
 
    Update on recent progress  
 
    ASX Appendix 3Z  
 
    Australian Roadshow Presentation  
 
    Appendix 4C - 31 January 2014  
 
    Interim financial statements - 31 December 2013  
 
    Changes to Board and Management  
 
    Simavita North American Roadshow Presentation  
Philippa Lewis, CEO of Simavita (TSXV.SV) (ASX.SVA), will deliver the attached presentation to investors in Toronto, New York and London between February and March, 2014. The investor roadshow will coincide with operational travel commitments.  
    Simavita CEO discusses today's ASX Listing  
 
    Foreign Entity Statement  
 
    Statement of Restricted Securities  
 
    Corporate Governance Policy  
 
    Corporate Governance Statement  
 
    Full Terms and Conditions of Warrants  
 
    Stock Option Plan  
 
    Updated Capital Structure  
 
    Updated Pro-Forma Statement of Financial Position  
 
    Updated Statement of Commitments  
 
    Gtech International Resources Limited Unaudited FS 31July13  
 
    Gtech International Resources Limited Financial Report 2013  
 
    Gtech International Resources Limited Financial Report 2012  
 
    Gtech International Resources Limited Financial Report 2011  
 
    Simavita Holdings Limited Financial Report 2013  
 
    Simavita Holdings Limited Financial Report 2012  
 
    Simavita Holdings Limited Financial Report 2011  
 
    Simavita Limited Unaudited Financial Statements 31 Oct 13  
 
    Simavita Limited Articles  
 
    Appendix 1A and Information Form and Checklist  
 
    Top 20 Holders  
 
    Distribution Schedule  
 
    Pre-Quotation Disclosure  
 
    ASX Notice - Admission and Commencement of Quotation  
 
    Admission to the Official List  
 
    Replacement Prospectus